This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Rosen S, Long L, Fox M, Sanne I.Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. JAIDS 48: 334-344, No. 3, 1 Jul 2008
Rights and permissions
About this article
Cite this article
Switch to first-line tenofovir DF warranted in South Africa. Pharmacoecon. Outcomes News 559, 12 (2008). https://doi.org/10.2165/00151234-200805590-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805590-00036